Year |
Citation |
Score |
2020 |
Wilson JE, Patel G, Patel C, Brucelle F, Huhn A, Gardberg AS, Poy F, Cantone N, Bommi-Reddy A, Sims RJ, Cummings RT, Levell JR. Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor. Acs Medicinal Chemistry Letters. 11: 1324-1329. PMID 32551019 DOI: 10.1021/Acsmedchemlett.0C00155 |
0.389 |
|
2020 |
Harvey EP, Hauseman ZJ, Cohen DT, Rettenmaier TJ, Lee S, Huhn AJ, Wales TE, Seo HS, Luccarelli J, Newman CE, Guerra RM, Bird GH, Dhe-Paganon S, Engen JR, Wells JA, et al. Identification of a Covalent Molecular Inhibitor of Anti-apoptotic BFL-1 by Disulfide Tethering. Cell Chemical Biology. PMID 32413285 DOI: 10.1016/J.Chembiol.2020.04.004 |
0.453 |
|
2020 |
Wilson JE, Huhn A, Gardberg AS, Poy F, Brucelle F, Vivat V, Patel G, Patel C, Cummings R, Sims R, Levell J, Audia JE, Bommi-Reddy A, Cantone N. Early Drug Discovery Efforts Towards the Identification of EP300/CBP Histone Acetyltransferase (HAT) Inhibitors. Chemmedchem. PMID 32181984 DOI: 10.1002/Cmdc.202000007 |
0.367 |
|
2019 |
Gardberg AS, Huhn AJ, Cummings R, Bommi-Reddy A, Poy F, Setser J, Vivat V, Brucelle F, Wilson J. Make the right measurement: Discovery of an allosteric inhibition site for p300-HAT. Structural Dynamics (Melville, N.Y.). 6: 054702. PMID 31649965 DOI: 10.1063/1.5119336 |
0.412 |
|
2019 |
Bommi-Reddy A, Wilson J, Huhn AJ, Terzo E, Poy F, Park S, Steinbaugh MJ, Bryant BM, Conery AR, Cummings R, Levell J, Sims RJ. Abstract 4722: Efficacy of a novel EP300/CBP histone acetyltransferase inhibitor in hormone responsive breast cancer Cancer Research. 79: 4722-4722. DOI: 10.1158/1538-7445.Am2019-4722 |
0.36 |
|
2017 |
Guerra RM, Huhn AJ, Harvey EP, Bird GH, Walensky LD. Abstract 2024: Reactivating apoptosis in BFL-1/A1 driven cancer with cysteine-reactive stapled peptide inhibitors Cancer Research. 77: 2024-2024. DOI: 10.1158/1538-7445.Am2017-2024 |
0.349 |
|
2016 |
Huhn AJ, Guerra RM, Harvey EP, Bird GH, Walensky LD. Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors. Cell Chemical Biology. PMID 27617850 DOI: 10.1016/J.Chembiol.2016.07.022 |
0.501 |
|
2016 |
Lee S, Wales TE, Escudero S, Cohen DT, Luccarelli J, Gallagher CG, Cohen NA, Huhn AJ, Bird GH, Engen JR, Walensky LD. Allosteric inhibition of antiapoptotic MCL-1. Nature Structural & Molecular Biology. PMID 27159560 DOI: 10.1038/Nsmb.3223 |
0.503 |
|
2016 |
Huhn AJ, Guerra RM, Bird GH, Walensky LD. Abstract 3845: A novel selectivity determinant informs the development of next-generation stapled peptide inhibitors of anti-apoptotic BFL-1/A1 Cancer Research. 76: 3845-3845. DOI: 10.1158/1538-7445.Am2016-3845 |
0.421 |
|
2016 |
Lee S, Wales TE, Gallagher C, Cohen DT, Escudero S, Luccarelli J, Huhn AJ, Cohen NA, Bird GH, Engen JR, Walensky LD. Abstract 3553: A novel allosteric mechanism for molecular inhibition of anti-apoptotic MCL-1 Cancer Research. 76: 3553-3553. DOI: 10.1158/1538-7445.Am2016-3553 |
0.511 |
|
2015 |
Edwards AL, Wachter F, Lammert M, Huhn AJ, Luccarelli J, Bird GH, Walensky LD. Cellular Uptake and Ultrastructural Localization Underlie the Pro-apoptotic Activity of a Hydrocarbon-stapled BIM BH3 Peptide. Acs Chemical Biology. PMID 26151238 DOI: 10.1021/Acschembio.5B00214 |
0.304 |
|
2014 |
Huhn AJ, Parsonage D, Horita DA, Torti FM, Torti SV, Hollis T. The high-molecular-weight kininogen domain 5 is an intrinsically unstructured protein and its interaction with ferritin is metal mediated. Protein Science : a Publication of the Protein Society. 23: 1013-22. PMID 24810540 DOI: 10.1002/Pro.2486 |
0.507 |
|
2012 |
Tesfay L, Huhn AJ, Hatcher H, Torti FM, Torti SV. Ferritin blocks inhibitory effects of two-chain high molecular weight kininogen (HKa) on adhesion and survival signaling in endothelial cells. Plos One. 7: e40030. PMID 22768328 DOI: 10.1371/Journal.Pone.0040030 |
0.421 |
|
2010 |
Huhn AJ, Parsonage D, Torti SV, Hollis T. Abstract 1285: The effects of the HK5-ferritin interaction and iron on tumor angiogenesis Cancer Research. 70: 1285-1285. DOI: 10.1158/1538-7445.Am10-1285 |
0.528 |
|
Show low-probability matches. |